Anti-fungal mechanisms Flashcards
Most important drugs to remember regarding Drug-Drug interactions via hepatic mechanisms
Azoles and Griseofulvin
Mitotic spindle inhibitor
Griseofulvin
Anti-metabolite
Flucytosine
Examples of endemic fungi that cause disease in immunocompromised pt.’s
histoplasma
coccidoides
paracoccidoides
Why are fungal infeaction increasing
- increases in medical technique (intravascular catheters)
- greater percentage of immunocompromised pt.’s are surviving with better treatments (eg. HIV, cancer, transplants)
* number of immunodefficient patient has grown–>therefore the rates have gone up
three classes of currently available anti-fungal drugs
- systemic drugs (oral or parenteral) for systemic infections
- oral systemic drugs for mucocutaneous infections
- topical drugs for mucocutaneous infections
types (areas) of fungal infections
*increase in severity as you go deeper
- superficial (from bad hygeine)
- cutaneous (ring worm and athletes foot)
- subcutaenous (from a wound)
- systemic
- opportunistic
Tx for aspergillosis
Voriconazole IV
Tx for Blastomycosis
itraconazole PO
Tx for blastomycosis
amphotericin B IV then Itraconazole PO
Tx for candidiasis
Fluconazole PO
Tx for coccidiomycosis
Fluconazole IV/PO or itraconazole PO
Tx for cryptococcus
3
*amphotericin B IV + Flucystosine PO, then Fluconazole PO
Tx for histoplasmosis
amphotericin B IV + itraconazole PO
Tx for mucomycosis
amphotericin B
Tx for sporotrichosis
amphotericine B IV and/or itraconazole PO
Flucytosine has only one indication….
cryptococcal infections
Drug class which inhibits membrane function
amphotericin B
Drugs class that disrupts ergosterol synthesis
Azoles, terbinafine, naftiline
Drugs that inhibit Cell Wall Synthesis
caspofungin (echocandins)
Drugs that inhibit nucleic acid synthesis
5-flourocytosine
MOA for terbinafine
blocks the conversion of squalene to squalene epoxide
toxic byproduct that accumulates due to terbinafine
squalene
Azole group MOA
prevents the conversion of lanosterol to ergosterol
Toxicity associated with amphotericin B
RENAL TOXICITY
amphotericin B MOA
amphipathic–> binds to ergosterol with its double bond side and H2O on its -OH side–> multiple drug molecules aggregate to form pores–> pores allow leakage, leading to cell death
most anti-fungal agents are
fungicidal
what accounts for prominent renal toxicity associated with amphotericin B
binding of human membrane sterols
Is Amphotericin B orally absorbed?
no
Amphotericin B–> means of administration
IV—> ALWAYS
Common adverse effects with amphotericin B: IMMEDIATE
“INFUSION-RELATED REACTIONS”
- fever chills, muscle spasms, vomiting, headache and HYPOtension
- premedications often given :antipyretic, antihistamines, meperidine, corticosteroids
Common adverse effects with amphotericin B:
DELAYED
“RENAL TOXICITY”
–sometimes necessitates dialysis
sodium loading to reduce pre-renal toxicity
anemia: due to loss of erythropoeitin
abnormal liver function tests
seizures: followoing intracthecal drug administration
will abnormalities resolve upon discontinuation of amphotericin B
Yes
Only drug comparable to amphotericin B
Nystatin
Uses for nystatin
topical application in tx of candidiasis
*identical mechanism of action to that of apmho B
nystatin can only be administered
topically
three types of candidiasis
mucocutaneous candidiasis
oropharyngeal candidiasis (thrush)
vulvovaginal candidiasis
“The fungins”
echinocandins